chr16-11556585-G-A

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM1BP4_StrongBS1BS2

The NM_001136472.2(LITAF):​c.146C>T​(p.Thr49Met) variant causes a missense change. The variant allele was found at a frequency of 0.00124 in 1,614,150 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00085 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 2 hom. )

Consequence

LITAF
NM_001136472.2 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:5

Conservation

PhyloP100: 4.74
Variant links:
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

PM1
In a chain Lipopolysaccharide-induced tumor necrosis factor-alpha factor (size 160) in uniprot entity LITAF_HUMAN there are 10 pathogenic changes around while only 1 benign (91%) in NM_001136472.2
BP4
Computational evidence support a benign effect (MetaRNN=0.049409658).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000847 (129/152260) while in subpopulation AMR AF= 0.00196 (30/15292). AF 95% confidence interval is 0.00141. There are 0 homozygotes in gnomad4. There are 55 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 129 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LITAFNM_001136472.2 linkuse as main transcriptc.146C>T p.Thr49Met missense_variant 2/4 ENST00000622633.5 NP_001129944.1 Q99732-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LITAFENST00000622633.5 linkuse as main transcriptc.146C>T p.Thr49Met missense_variant 2/41 NM_001136472.2 ENSP00000483114.1 Q99732-1

Frequencies

GnomAD3 genomes
AF:
0.000848
AC:
129
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00116
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.000593
AC:
149
AN:
251306
Hom.:
0
AF XY:
0.000582
AC XY:
79
AN XY:
135852
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.000933
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.00128
AC:
1872
AN:
1461890
Hom.:
2
Cov.:
32
AF XY:
0.00123
AC XY:
894
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.000760
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00158
Gnomad4 OTH exome
AF:
0.00101
GnomAD4 genome
AF:
0.000847
AC:
129
AN:
152260
Hom.:
0
Cov.:
32
AF XY:
0.000739
AC XY:
55
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.00196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.00116
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.000922
Hom.:
0
Bravo
AF:
0.000824
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000519
AC:
63
EpiCase
AF:
0.000654
EpiControl
AF:
0.000889

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease Pathogenic:1Benign:1
Likely benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Likely pathogenic, no assertion criteria providedliterature onlyInherited Neuropathy Consortium-- -
Charcot-Marie-Tooth disease type 1C Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 30, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2023LITAF: BS1 -
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 24, 2020This variant is associated with the following publications: (PMID: 25058650, 15776429, 16373087, 23576546, 28211240, 16775366, 16877806, 26220970, 32376792) -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsDec 21, 2021This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
18
DANN
Benign
0.64
DEOGEN2
Benign
0.35
T;T;.;T;.;T;T;T;T;T;.;.;.;.;T;T
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.46
N
LIST_S2
Uncertain
0.89
.;D;.;.;D;.;D;.;.;D;D;D;D;D;D;D
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.049
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Benign
1.7
L;L;L;L;L;L;.;L;L;.;.;L;.;.;.;.
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.52
.;.;N;N;N;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.25
Sift
Benign
0.071
.;.;T;T;D;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.16
T;T;T;T;T;T;T;T;T;.;.;T;.;T;D;D
Polyphen
0.43
B;B;.;B;D;B;.;B;B;.;.;.;.;.;.;.
Vest4
0.37
MVP
0.97
MPC
0.16
ClinPred
0.064
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.032
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141862602; hg19: chr16-11650441; API